Breast Uptake of Radio-iodine in Differentiated Thyroid Cancer

Author Info

Kanchan Kulkarni

Corresponding Author

Kanchan Kulkarni
Medstar Medical Group Radiology, Medstar Washington Hospital Center, Division of Nuclear Medicine, Washington, D.C., USA

A B S T R A C T

Radioiodine is often seen to accumulate within breast tissue in patients with differentiated thyroid cancer. Although the risk of secondary breast malignancy in patients with differentiated thyroid cancer treated with radioiodine is controversial, the identification and reduction of this uptake is prudent to minimize the radiation absorbed dose to the breast tissue. This article reviews the literature describing the etiology, frequency and patterns of radioiodine uptake in breast tissue. Approaches and techniques to help minimize the radioiodine uptake in lactating and nonlactating breasts are presented.

Article Info

Article Type

Review Article

Publication history

Received: Mon 25, May 2020
Accepted: Mon 08, Jun 2020
Published: Tue 23, Jun 2020

Copyright

© 2023 Kanchan Kulkarni. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI: 10.31487/j.RDI.2020.02.08